Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients

被引:14
作者
Aviram, A [1 ]
Blickstein, D [1 ]
Stark, P [1 ]
Luboshitz, J [1 ]
Bairey, O [1 ]
Prokocimer, M [1 ]
Shaklai, M [1 ]
机构
[1] Rabin Med Ctr, Div Hematol, IL-49100 Petah Tiqwa, Israel
关键词
myeloproliferative disorders; essential thrombocythemia; Philadelphia chromosome; BCR-ABL;
D O I
10.3109/10428199909093727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Philadelphia-negative (Ph-neg) essential thrombocythemia (ET), polycythemia vera (PV) and idiopathic myelofibrosis (IMF) form a syndrome of related chronic myeloproliferative disorders (MPD) characterized by expansion of one or more of the hematopoietic progenitors. Based on our previous finding of BCR-ABL transcripts in bone marrow aspirates of 12/25 Ph-neg ET patients, we have expanded our study up to 40 patients. Here we describe the rational for performing this study and report 19 of 40 patients who have BCR-ABL transcripts in their BM, 11 of them carry b3a2 and 8 carry b2a2. The two groups, BCR-ABL positive and negative, were completely identical with regard to clinical characteristics and laboratory data. We also report preliminary results of our attempt to examine concordance or discordance of BCR-ABL expression in the peripheral blood and bone marrow of Ph-neg ET patients.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 32 条
[1]   PRIMARY POLYCYTHEMIA, ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS - 3 FACETS OF A SINGLE DISEASE PROCESS [J].
ADAMS, JA ;
BARRETT, AJ ;
BEARD, J ;
MCCARTHY, DM .
ACTA HAEMATOLOGICA, 1988, 79 (01) :33-37
[2]  
ARDERN JC, 1993, CLIN LAB HAEMATOL, V15, P253
[3]  
BEDI A, 1994, BLOOD, V83, P2038
[4]   THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].
BEN-NERIAH, Y ;
DALEY, GQ ;
MESMASSON, AM ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1986, 233 (4760) :212-214
[5]   BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients: Clinical presentation [J].
Blickstein, D ;
Aviram, A ;
Luboshitz, J ;
Prokocimer, M ;
Stark, P ;
Bairey, O ;
Sulkes, J ;
Shaklai, M .
BLOOD, 1997, 90 (07) :2768-2771
[6]  
CERVANTES F, 1993, LEUKEMIA, V7, P327
[7]  
CROZIAT H, 1983, BLOOD, V62, P578
[8]   GENETIC MECHANISMS IN TUMOR INITIATION AND PROGRESSION .7. ONCOGENE ACTIVATION BY CHROMOSOMAL REARRANGEMENT IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
DEKLEIN, A .
MUTATION RESEARCH, 1987, 186 (02) :161-172
[9]   CIRCULATING PLURIPOTENT HEMATOPOIETIC-CELLS IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS [J].
DOUER, D ;
FABIAN, I ;
CLINE, MJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1983, 54 (03) :373-381
[10]   Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets [J].
ElKassar, N ;
Hetet, G ;
Briere, J ;
Grandchamp, B .
BLOOD, 1997, 89 (01) :128-134